Paper35938677
Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.
Zheng TJ and 7 others. Am J Physiol Cell Physiol, 2022. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology. Papers, record 35938677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35938677
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemostatics | Major topic |
| Platelet Activation | Major topic |
| Agammaglobulinaemia Tyrosine Kinase | |
| Blood Platelets | |
| Janus Kinases | |
| Platelet Aggregation | |
| Platelet Glycoprotein GPIIb-IIIa Complex | |
| Protein Kinase Inhibitors | |
| Syk Kinase | |
| Tyrosine | |
| src-Family Kinases |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F30 HL158079 | NHLBI NIH HHS | United States | F30HL158079 | PubMed and NIH | NIH RePORTER |
| R01 HL101972 | NHLBI NIH HHS | United States | R01HL101972 | PubMed | NIH RePORTER |
| R01 HL151367 | NHLBI NIH HHS | United States | R01HL151367 | PubMed and NIH | NIH RePORTER |
| R01 HL146549 | NHLBI NIH HHS | United States | R01HL146549 | PubMed and NIH | NIH RePORTER |
| P20 GM103443 | NIGMS NIH HHS | United States | P20GM103443 | PubMed and NIH | NIH RePORTER |
References217
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32631841 | JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk. | Eur Respir J | 2020 | https://conductscience.org/library/papers/32631841 | PubMed |
| 2 | 30692122 | Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib. | Blood | 2019 | https://conductscience.org/library/papers/30692122 | PubMed |
| 3 | 12006504 | Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. | Clin Cancer Res | 2002 | https://conductscience.org/library/papers/12006504 | PubMed |
| 4 | 30819914 | Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions. | Haematologica | 2019 | https://conductscience.org/library/papers/30819914 | PubMed |
| 5 | 24779514 | Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase. | J Med Chem | 2014 | https://conductscience.org/library/papers/24779514 | PubMed |
| 6 | 21058007 | Platelet receptor signaling in thrombus formation. | J Mol Med (Berl) | 2011 | https://conductscience.org/library/papers/21058007 | PubMed |
| 7 | 30030853 | The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen-induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC). | Eur J Haematol | 2018 | https://conductscience.org/library/papers/30030853 | PubMed |
| 8 | 25900780 | Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis. | J Thromb Haemost | 2015 | https://conductscience.org/library/papers/25900780 | PubMed |
| 9 | 34130349 | Tyrosine Kinase Inhibitor Sunitinib Delays Platelet-Induced Coagulation: Additive Effects of Aspirin. | Thromb Haemost | 2022 | https://conductscience.org/library/papers/34130349 | PubMed |
| 10 | 30685871 | Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib. | Thromb Haemost | 2019 | https://conductscience.org/library/papers/30685871 | PubMed |
| 11 | 16002463 | Role of tyrosine kinase inhibitors in cancer therapy. | J Pharmacol Exp Ther | 2005 | https://conductscience.org/library/papers/16002463 | PubMed |
| 12 | 34839996 | Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib. | Eur J Med Chem | 2022 | https://conductscience.org/library/papers/34839996 | PubMed |
| 13 | 10506151 | The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10506151 | PubMed |
| 14 | 20189992 | An important role of the SRC family kinase Lyn in stimulating platelet granule secretion. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20189992 | PubMed |
| 15 | 17158345 | Activation of platelet function through G protein-coupled receptors. | Circ Res | 2006 | https://conductscience.org/library/papers/17158345 | PubMed |
| 16 | 26371140 | Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26371140 | PubMed |
| 17 | 10704823 | Tyrosine phosphorylation and association of FcgammaRII and p72(Syk) are not limited to the FcgammaRII signalling pathway. | Cell Signal | 2000 | https://conductscience.org/library/papers/10704823 | PubMed |
| 18 | 29269020 | TCR Signaling: Mechanisms of Initiation and Propagation. | Trends Biochem Sci | 2018 | https://conductscience.org/library/papers/29269020 | PubMed |
| 19 | 22201778 | FES/FER kinase signaling in hematopoietic cells and leukemias. | Front Biosci (Landmark Ed) | 2012 | https://conductscience.org/library/papers/22201778 | PubMed |
| 20 | 33537526 | Protease-activated receptors: An illustrated review. | Res Pract Thromb Haemost | 2021 | https://conductscience.org/library/papers/33537526 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42619595 | Monovalent Anti-FcγRIIA Antibody Blocks Immune-Mediated Thrombocytopenia and Thrombosis With Minimal Adverse Side Effects in Mice. | Arterioscler Thromb Vasc Biol | 2026 | https://conductscience.org/library/papers/42619595 | PubMed |
| 42181826 | Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib. | Eur Heart J Case Rep | 2026 | https://conductscience.org/library/papers/42181826 | PubMed |
| 42148361 | Development Trends of Janus Kinase Inhibitors (JAKi) Over Three Decades: From Common to Rare Diseases. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42148361 | PubMed |
| 41896928 | Proteomic remodeling during tumor cell-induced platelet aggregation unveils metastatic drivers in colorectal cancer. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/41896928 | PubMed |
| 41458387 | Spleen and Bruton's tyrosine kinase inhibitors for the management of adult immune thrombocytopenia: A systematic review and meta-analysis of randomized controlled trials. | Clin Hematol Int | 2025 | https://conductscience.org/library/papers/41458387 | PubMed |
| 41142963 | An overview of advanced nanocarrier systems for Ibrutinib delivery: overcoming pharmacokinetic barriers and enabling targeted cancer therapy. | Int J Pharm X | 2025 | https://conductscience.org/library/papers/41142963 | PubMed |
| 40952587 | Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/40952587 | PubMed |
| 40886252 | Structure-guided discovery of a novel BTK inhibitor inducing apoptosis and G1 phase arrest in tumor cells. | Mol Divers | 2026 | https://conductscience.org/library/papers/40886252 | PubMed |
| 40728654 | JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis. | Curr Atheroscler Rep | 2025 | https://conductscience.org/library/papers/40728654 | PubMed |
| 40532792 | Current and future landscape of Bruton tyrosine kinase inhibitors in allergy. | J Allergy Clin Immunol | 2025 | https://conductscience.org/library/papers/40532792 | PubMed |
| 39893011 | Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function. | J Pharmacol Exp Ther | 2025 | https://conductscience.org/library/papers/39893011 | PubMed |
| 39374578 | Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction. | Blood Adv | 2025 | https://conductscience.org/library/papers/39374578 | PubMed |
| 38994958 | TGF-β-Based Therapies for Treating Ocular Surface Disorders. | Cells | 2024 | https://conductscience.org/library/papers/38994958 | PubMed |
| 36858794 | Fibrin reaches out to GPVI to influence how platelets shape clots. | J Thromb Haemost | 2023 | https://conductscience.org/library/papers/36858794 | PubMed |
| 36219587 | Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity. | Blood Adv | 2023 | https://conductscience.org/library/papers/36219587 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BTK | 695 | PubTator's text mining | https://conductscience.org/library/genes/695 | NCBI Gene |
| SYK | 6850 | PubTator's text mining | https://conductscience.org/library/genes/6850 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35938677
GET https://conductscience.org/api/papers/v1/35938677/references?page=2